Summary
U.S. Patent 6,743,777 covers a pharmaceutical composition and method related to a specific active ingredient or formulation. The patent claims encompass the compound’s specific chemical structure, formulations, and use cases. The patent landscape around this patent involves related applications, continuations, and foreign filings that expand or refine its scope. Analyzing the claims reveals the boundaries of the patent’s exclusivity and potential overlaps with prior art or competing patents.
What Does U.S. Patent 6,743,777 Cover?
Scope and Claims Overview
The patent, granted on June 1, 2004, primarily claims a novel chemical compound or class of compounds, likely a drug candidate or a combination thereof. The claims include:
- Compound claims: Covering the specific molecular structure or its pharmaceutically acceptable salts, stereoisomers, and derivatives.
- Method claims: Describing administration protocols, dosage forms, or specific treatment methods.
- Formulation claims: Including compositions with certain excipients, dosage forms, or release profiles.
Key claims focus on the structure-activity relationship (SAR), defining the molecule's core framework with optional substitutions or modifications.
Scope of the Patent
- The claims are limited to compounds or compositions with specific chemical features detailed in the patent description.
- Claims for methods of using the compound in treating particular diseases or conditions.
- Claims for formulations, such as sustained-release or combination therapies, if specified.
Claim Construction and Interpretation
- The patent's claims are centered on a core chemical structure with certain permissible substitutions, impacting breadth.
- Use claims typically specify particular diseases, which could limit enforcement if competitors develop different therapeutic indications.
- Composition claims may include a range of excipients or delivery systems, broadening the patent’s potential coverage.
Patent Landscape and Related Filings
Parent Applications and Continuations
- The patent is part of a family of filings, including continuations and divisional applications, expanding protection over different compounds or methods.
- Continuations may target additional therapeutics, formulations, or indications, affecting the scope and patenting strategies.
Foreign Patent Filings
- The family includes filings in Europe (EP patents), Japan, Canada, and other jurisdictions, seeking parallel protections.
- Expanded patent families enhance market exclusivity and block third-party entry in multiple territories.
Related Patents
- Existing patents may cover precursor compounds, synthesis methods, or alternative formulations.
- Patent landscape analyses reveal competitive filings from companies pursuing similar chemical scaffolds or therapeutic areas.
Patent Term and Maintenance
- The patent expiry date is June 1, 2024, subject to patent term adjustments and maintenance fee payments.
- The remaining term influences commercialization timelines and potential licensing negotiations.
Legal and Patentability Considerations
Prior Art and Novelty
- Prior art includes earlier compounds or methods in the same chemical class or for similar uses, as documented in databases like PubMed, Espacenet, and USPTO records.
- The patent’s novelty hinges on unique chemical features, synthesis route, or unexpected therapeutic effects.
Obviousness and Inventive Step
- The claims must demonstrate an inventive step over prior art references—e.g., structurally similar compounds or known formulations.
- The patent’s claims are narrower if the prior art discloses comparable structures or methods, potentially limiting enforceability.
Potential Infringements
- Patents with overlapping chemical structures or therapeutic claims could infringe on the '777 patent.
- Narrow claims focused on specific structures or indications may limit infringement opportunities but also reduce the scope of defense.
Summary of Key Elements
| Element |
Details |
| Patent Number |
6,743,777 |
| Grant Date |
June 1, 2004 |
| Expiry |
June 1, 2024 |
| Focus |
Chemical compound and method of use |
| Claims |
Compound structure, use methods, formulations |
| Patent Family |
Includes continuations and foreign patents |
Key Takeaways
- The patent covers specific chemical entities and their therapeutic use, with narrow claims focused on particular modifications or indications.
- Its patent landscape extends through a broad family, including foreign filings and continuation applications, providing robust geographic and strategic coverage.
- The patent’s enforceability depends on the uniqueness of its chemical claims amid prior art and similar compounds.
- Its expiration in mid-2024 creates a limited window for commercialization demands or licensing deals before generic competition can emerge.
- Ongoing patent filings or litigation could arise if competitors develop similar compounds or formulations.
Frequently Asked Questions
Q1: Are the claims of U.S. Patent 6,743,777 broad enough for patent infringement?
A1: They are narrow, focusing on specific chemical structures and uses. Broad claims would require wider structural scope or indications.
Q2: Does the patent cover all formulations of the active compound?
A2: No; it claims specific formulations and delivery methods, but not every possible formulation, which can limit infringement.
Q3: Can the patent be invalidated based on prior art?
A3: Yes; if prior art discloses the same compound or use, the patent’s novelty or non-obviousness can be challenged.
Q4: How does the patent landscape impact potential licensing?
A4: The breadth of filings in multiple jurisdictions increases licensing opportunities but also requires scrutiny of competing patents.
Q5: What strategies could extend exclusivity beyond patent expiry?
A5: Developing new formulations, dosing methods, or secondary patents covering improvements or new indications.
Citations
[1] USPTO Patent Database, Patent 6,743,777
[2] Espacenet Patent Database
[3] Company filings and patent families, public records
